source
- A leader of the 2014 U.S. Ebola response compares then to nowAs the world deals with an outbreak of Ebola that has no known cure, Susan Reichle, who last year co-founded Aid Transition Alliance to support former USAID professionals, discusses the…STAT · 1mo ago↗ source
- STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6BGSK is buying Nuvalent, the maker of targeted cancer drugs, for $10.6 billion, a sizable addition to the latest run of biopharma acquisitions.STAT · 1mo ago↗ source
- GSK to acquire Nuvalent and its two cancer drugs under FDA review for $10.6BGSK is making one of the largest biotech acquisitions in its history to gain access to two experimental lung cancer medicines that are due for FDA approval decisions later this year. The UK drugmak…